Qiran Zhang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Efficacy and Safety of Pegylated Interferon as Rescue Therapy for Patients with Chronic Hepatitis B Who Failed to Achieve Functional Cure After Antisense Oligonucleotides or Small Interfering RNA: A Prospective, Multicentre, Open-Label Randomized Controlled Trial (SPHERE) Protocol.
Journal: Advances in therapy
Published: February 06, 2026
Application of Droplet Digital PCR in Sputum Samples in Myasthenia Gravis Patients with Pneumonia.
Journal: Infection and drug resistance
Published: December 15, 2025
Safety and HBsAg reduction with a lentiviral vaccine J-51 in chronic hepatitis B: An investigator-initiated pilot trial.
Journal: Molecular therapy. Advances
Published: November 22, 2025
The incidence of spontaneous HBsAg loss in patients with different baseline HBsAg levels: a systematic review and meta-analysis.
Journal: Hepatology international
Published: November 05, 2025
Host-viral interaction of HBV infection revealed by single-cell transcriptome jointly profiling the viral replication state.
Journal: Hepatology (Baltimore, Md.)
Published: August 09, 2025
Predictive model for HBsAg clearance rate in chronic hepatitis B patients treated with pegylated interferon α-2b for 48 weeks.
Journal: Hepatology international
Published: September 13, 2024
The High Expression of PD-1 Defines A Subpopulation of Tfh Cells Responding to COVID-19 Vaccine in Humans.
Journal: Genomics, proteomics & bioinformatics
Published: July 15, 2024
Clinical Characteristics, Treatment, and Prognosis of Osteoarticular Brucellosis: A Retrospective Real-World Study in Shenyang, China, 2014-2019.
Journal: Foodborne pathogens and disease
Published: April 12, 2024
A RISC-V 32-bit microprocessor based on two-dimensional semiconductors.
Journal: Nature
Published: February 22, 2024
PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial.
Journal: Journal of hepatology
Published: January 15, 2024
Correction to: Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study.
Journal: Hepatology international
Published: September 22, 2023
Last Updated: 09/26/2026